Pharmafile Logo
Pharmafocus logo
Advanced Search

US

Showing 15 posts of 324 posts found.

Pfizer’s Daurismo becomes first of its kind to secure FDA approval in acute myeloid leukaemia

November 22, 2018
Research and Development, Sales and Marketing AML, Daurismo, FDA, Pfizer, US, leukaemia

Pfizer has revealed that the FDA has chosen to approve its Daurismo (glasdegib) for the treatment of newly-diagnosed acute myeloid …

News
shutterstock_138095450

Opioid dependency therapy price hiked 600% since 2014, Senate investigators find

November 20, 2018
Manufacturing and Production, Sales and Marketing Evzio, Kaleo, Senate, US, naloxone, opioid crisis, opioid epidemic, opioids, pharma

Senate investigators have found that Virginia-based drugmaker Kaleo hiked the price of its opioid dependency therapy Evzio (naloxone) by as …

News

Novartis’ Promacta cleared by FDA for first-line use in severe aplastic anaemia

November 19, 2018
Sales and Marketing FDA, Novartis, Promacta, Revolade, US, aplastic anaemia, pharma

Novartis has secured expanded approval from the FDA for Promacta (eltrombopag), allowing it to now be used in combination with …

News
msd

MSD’s Keytruda chalks up FDA approval in liver cancer

November 12, 2018
Sales and Marketing Cancer, FDA, US, hepatocellular carcinoma, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda has secured another FDA approval, this time for the treatment of hepatocellular carcinoma (HCC) in patients …

News

FDA approves BMS’ multiple myeloma combo after it doubles progression-free survival

November 7, 2018
Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Empliciti, FDA, US, multiple myeloma, pharma

The FDA has seen fit to approve Bristol-Myers Squibb’s Empliciti (elotuzumab) intravenous injection in combination with pomalidomide and dexamethasone for …

News

FDA controversially approves potent opioid up to ten times stronger than fentanyl

November 6, 2018
Sales and Marketing Dsuvia, FDA, US, fentanyl, opioid crisis, opioids, pharma

Despite voices of criticism, the FDA has opted to approve AcelRX’s Dsuvia (sufentanil), an opioid medication said to be five …

News
donald_trump_8567813820_2

President Trump unveils new plans to bring US drug prices in line with the rest of the world

October 26, 2018
Medical Communications, Sales and Marketing Drug pricing, Trump, US, pharma

Two weeks before the all-important midterm elections in the US, and after repeated strongly-worded promises, President Trump has unveiled an …

News
gsk_boronia_australia

GSK to axe 99 positions at Memphis site

October 18, 2018
Manufacturing and Production GSK, US, pharma

GlaxoSmithKline’s workforce on President’s Island in Memphis, US, is set to see the loss of 99 employees, as revealed in …

News
trvn1

Trevena’s opioid injection fails to win over FDA committee

October 12, 2018
Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma

Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …

News

Novartis forge deal with Boston Pharmaceuticals in effort against AMR

October 3, 2018
Research and Development AMR, Antibiotics, Boston Pharmaceuticals, Novartis, US

Swiss multinational Novartis have entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel …

News
novo_nordisk_flag

Novo Nordisk cuts 650 roles around the world in R&D restructure

October 1, 2018
Manufacturing and Production, Sales and Marketing China, Denmark, Novo Nordisk, UK, US, pharma

Novo Nordisk has announced a wave of jobs cuts as part of a global restructure of its $1 billion R&D …

News
pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …

News
opioid_pills

Surgeon General calls for cultural shift in approach to opioid crisis

September 21, 2018
Medical Communications Trump, US, opioid crisis, opioid epidemic, surgeon general

The Surgeon General of the United States has called for a cultural shift in the way in which Americans talk …

News
white-house-13863_960_720

Senate bill would save money and allow generics to reach market more quickly, according to CBO report

September 20, 2018
Business Services, Medical Communications, Sales and Marketing CBO, Senate, US, biosimilars, generics, law, politics

The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate …

News
sicorbio

FDA greenlights Teva’s migraine drug Ajovy in two dosage options

September 20, 2018
Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025